FDA Adverse Event Injury Summary report: N

3.0MM TI ELASTIC NAIL 440MM

MDR report key: 2974366 · Received February 22, 2013

Report

Report Number
2520274-2013-01105
Event Type
Injury
Date Received
February 22, 2013
Report Date
January 24, 2013
Manufacturer
SYNTHES USA
Product Code
HTY
PMA / PMN Number
K971783
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS DEVICE IS USED FOR TREATMENT, NOT DIAGNOSIS. REVIEW OF THE DESIGN HISTORY FILE AND RISK ANALYSIS SHOWED THERE IS A FREQUENCY OF LESS THAN (B)(4) OF THIS REPORTED EVENT. FACTORS THAT MAY CONTRIBUTE TO NON-UNIONS INCLUDE IMPLANT SELECTION FOR SIZE AND TYPE OR PATIENT NON-COMPLIANCE.

Additional Manufacturer Narrative · 1

DEVICE WAS USED FOR TREATMENT, NOT DIAGNOSIS. IMPLANT DATE REPORTED AS APPROXIMATELY (B)(6) 2012 WITHOUT A LOT NUMBER THE DEVICE HISTORY RECORDS REVIEW COULD NOT BE COMPLETED. THE PRODUCT INVESTIGATION IS CURRENTLY IN THE EVALUATION PROCESS. A MANUFACTURING EVALUATION REVEALED THE FOLLOWING: BECAUSE OF THE DAMAGE TO THE PART, NO ACCURATE MEASUREMENT CAN BE MADE OTHER THAN THE DIAMETER AND THE RAW MATERIAL. THIS COMPLAINT IS DEEMED INDETERMINATE.

Description of Event or Problem · 1

IN (B)(6) 2012, A PATIENT WAS IMPLANTED WITH TWO TI ELASTIC NAILS FOR A LEFT FEMUR FRACTURE. IN (B)(6) 2012, THE PATIENT PRESENTED TO A DIFFERENT SURGEON IN ANOTHER FACILITY COMPLAINING OF PAIN AND A BOWED FEMUR. EXAMINATIONS AND X-RAYS SHOWED A LOSS OF REDUCTION, NON-UNION OF THE FEMUR, AND BENDING OF THE ELASTIC NAILS. IN (B)(6) 2012, RESTRICTIONS WHERE PRESCRIBED FOR USE OF CRUTCHES AND NON-BEARING WEIGHT. ON (B)(6) 2013, THE PATIENT RETURNED TO THE OPERATING ROOM AND THE ELASTIC NAILS WERE REMOVED AND REPLACED WITH ANTEGRADE LATERAL FEMORAL NAILS. THE PATIENT IS REPORTEDLY RECOVERING WELL. THIS IS 2 OF 2 REPORTS FOR THE SAME EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
78903 3.0MM TI ELASTIC NAIL 440MM PIN, FIXATION, SMOOTH HTY SYNTHES USA

Patients

Seq Age Sex Outcome Treatment
1 14 YR Required Intervention